AUTOSCOPE TECHNOLOGIES CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that AUTOSCOPE TECHNOLOGIES CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $8.50M | Mar 22, 2022 |
| FY2021 | Dec 31, 2020 | $8.30M | Mar 22, 2022 |
| FY2020 | Dec 31, 2019 | $8.30M | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | $8.90M | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | $8.60M | Mar 14, 2019 |
| FY2017 | Dec 31, 2016 | $14.14M | Mar 14, 2018 |
| FY2016 | Dec 31, 2015 | $15.22M | Mar 24, 2017 |
| FY2015 | Dec 31, 2014 | $18.14M | Mar 10, 2016 |
| FY2015 | Dec 31, 2013 | $19.84M | Mar 10, 2016 |
| FY2014 | Dec 31, 2012 | $24.96M | Mar 20, 2015 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $14.52M | Mar 14, 2018 |
| FY2017 | Dec 31, 2016 | $14.14M | Mar 14, 2018 |
| FY2016 | Dec 31, 2015 | $15.22M | Mar 24, 2017 |
| FY2015 | Dec 31, 2014 | $18.14M | Mar 10, 2016 |
| FY2015 | Dec 31, 2013 | $19.84M | Mar 10, 2016 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $10.24M | Mar 22, 2022 |
| FY2021 | Dec 31, 2020 | $10.39M | Mar 22, 2022 |
| FY2020 | Dec 31, 2019 | $11.60M | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | $11.78M | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | $11.60M | Mar 14, 2019 |
| FY2017 | Dec 31, 2016 | $10.04M | Mar 14, 2018 |
| FY2016 | Dec 31, 2015 | $11.74M | Mar 24, 2017 |
| FY2015 | Dec 31, 2014 | $13.56M | Mar 10, 2016 |
| FY2015 | Dec 31, 2013 | $13.42M | Mar 10, 2016 |
| FY2014 | Dec 31, 2012 | $18.26M | Mar 20, 2015 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $2.30M | Mar 22, 2022 |
| FY2021 | Dec 31, 2020 | $1.06M | Mar 22, 2022 |
| FY2020 | Dec 31, 2019 | $7.00M | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | $1.86M | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | $2.08M | Mar 14, 2019 |
| FY2017 | Dec 31, 2016 | $687.0K | Mar 14, 2018 |
| FY2016 | Dec 31, 2015 | ($3.10M) | Mar 24, 2017 |
| FY2015 | Dec 31, 2014 | ($9.70M) | Mar 10, 2016 |
| FY2015 | Dec 31, 2013 | ($15.90M) | Mar 10, 2016 |
| FY2014 | Dec 31, 2012 | ($3.35M) | Mar 20, 2015 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $2.27M | Mar 22, 2022 |
| FY2021 | Dec 31, 2020 | $608.0K | Mar 22, 2022 |
| FY2020 | Dec 31, 2019 | $1.83M | Mar 11, 2021 |
| FY2018 | Dec 31, 2018 | $1.85M | Mar 14, 2019 |
| FY2018 | Dec 31, 2017 | $2.12M | Mar 14, 2019 |
| FY2017 | Dec 31, 2016 | $687.0K | Mar 14, 2018 |
| FY2016 | Dec 31, 2015 | $380.0K | Mar 24, 2017 |
| FY2015 | Dec 31, 2014 | ($2.25M) | Mar 10, 2016 |
| FY2015 | Dec 31, 2013 | ($7.44M) | Mar 10, 2016 |
| FY2014 | Dec 31, 2012 | ($3.56M) | Mar 20, 2015 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $2.21M | Mar 22, 2022 |
| FY2021 | Dec 31, 2020 | $3.34M | Mar 22, 2022 |
| FY2020 | Dec 31, 2019 | $2.84M | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | $3.28M | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | $3.01M | Mar 14, 2019 |
| FY2017 | Dec 31, 2016 | $2.95M | Mar 14, 2018 |
| FY2016 | Dec 31, 2015 | $3.52M | Mar 24, 2017 |
| FY2015 | Dec 31, 2014 | $4.86M | Mar 10, 2016 |
| FY2015 | Dec 31, 2013 | $3.71M | Mar 10, 2016 |
| FY2014 | Dec 31, 2012 | $4.14M | Mar 20, 2015 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $2.56M | Mar 22, 2022 |
| FY2021 | Dec 31, 2020 | $2.56M | Mar 22, 2022 |
| FY2020 | Dec 31, 2019 | $2.25M | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | $1.66M | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | $2.95M | Mar 14, 2019 |
| FY2016 | Dec 31, 2016 | $447.0K | Mar 24, 2017 |
| FY2016 | Dec 31, 2015 | ($1.78M) | Mar 24, 2017 |
| FY2015 | Dec 31, 2014 | ($2.58M) | Mar 10, 2016 |
| FY2015 | Dec 31, 2013 | ($5.52M) | Mar 10, 2016 |
| FY2014 | Dec 31, 2012 | $5.94M | Mar 20, 2015 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $2.09M | Mar 22, 2022 |
| FY2021 | Dec 10, 2021 | $230.1K | Mar 22, 2022 |
| FY2021 | Dec 31, 2020 | $129.0K | Mar 22, 2022 |
| FY2020 | Dec 31, 2019 | $254.0K | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | $194.0K | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | $300.0K | Mar 14, 2019 |
| FY2017 | Dec 31, 2016 | $163.0K | Mar 14, 2018 |
| FY2016 | Dec 31, 2015 | $150.0K | Mar 24, 2017 |
| FY2015 | Dec 31, 2014 | $298.0K | Mar 10, 2016 |
| FY2015 | Dec 31, 2013 | $300.0K | Mar 10, 2016 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $22.37M | Mar 22, 2022 |
| FY2021 | Dec 31, 2020 | $21.42M | Mar 22, 2022 |
| FY2020 | Dec 31, 2019 | $19.18M | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | $13.48M | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | $11.13M | Mar 14, 2019 |
| FY2017 | Dec 31, 2016 | $8.20M | Mar 14, 2018 |
| FY2016 | Dec 31, 2015 | $8.97M | Mar 24, 2017 |
| FY2015 | Dec 31, 2014 | $14.89M | Mar 10, 2016 |
| FY2014 | Dec 31, 2013 | $24.39M | Mar 20, 2015 |
| FY2013 | Dec 31, 2012 | $38.54M | Mar 6, 2014 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $2.57M | Mar 22, 2022 |
| FY2021 | Dec 31, 2020 | $2.05M | Mar 22, 2022 |
| FY2020 | Dec 31, 2019 | $1.25M | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | $2.85M | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | $2.49M | Mar 14, 2019 |
| FY2017 | Dec 31, 2016 | $2.00M | Mar 14, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $19.79M | Mar 22, 2022 |
| FY2021 | Dec 31, 2020 | $19.37M | Mar 22, 2022 |
| FY2021 | Dec 31, 2019 | $17.93M | Mar 22, 2022 |
| FY2020 | Dec 31, 2018 | $10.64M | Mar 11, 2021 |
| FY2019 | Dec 31, 2017 | $8.64M | Mar 12, 2020 |
| FY2017 | Dec 31, 2016 | $6.21M | Mar 14, 2018 |
| FY2016 | Dec 31, 2015 | $5.40M | Mar 24, 2017 |
| FY2015 | Dec 31, 2014 | $8.32M | Mar 10, 2016 |
| FY2015 | Dec 31, 2013 | $18.51M | Mar 10, 2016 |
| FY2015 | Dec 31, 2012 | $33.98M | Mar 10, 2016 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2011 | Dec 31, 2011 | $3.12M | Mar 19, 2012 |
| FY2011 | Dec 31, 2010 | $14.71M | Mar 19, 2012 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | ($5.14M) | Mar 22, 2022 |
| FY2021 | Dec 31, 2020 | ($5.50M) | Mar 22, 2022 |
| FY2020 | Dec 31, 2019 | ($6.57M) | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | ($13.59M) | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | ($15.46M) | Mar 14, 2019 |
| FY2017 | Dec 31, 2016 | ($17.53M) | Mar 14, 2018 |
| FY2016 | Dec 31, 2015 | ($18.22M) | Mar 24, 2017 |
| FY2015 | Dec 31, 2014 | ($15.12M) | Mar 10, 2016 |
| FY2014 | Dec 31, 2013 | ($5.42M) | Mar 20, 2015 |
| FY2013 | Dec 31, 2012 | $10.49M | Mar 6, 2014 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $8.23M | Mar 22, 2022 |
| FY2021 | Dec 31, 2020 | $8.61M | Mar 22, 2022 |
| FY2021 | Dec 31, 2019 | $5.12M | Mar 22, 2022 |
| FY2020 | Dec 31, 2018 | $4.24M | Mar 11, 2021 |
| FY2019 | Dec 31, 2017 | $3.19M | Mar 12, 2020 |
| FY2018 | Dec 31, 2016 | $1.55M | Mar 14, 2019 |
| FY2017 | Dec 31, 2015 | $2.65M | Mar 14, 2018 |
| FY2016 | Dec 31, 2014 | $2.66M | Mar 24, 2017 |
| FY2015 | Dec 31, 2013 | $3.56M | Mar 10, 2016 |
| FY2015 | Dec 31, 2012 | $8.33M | Mar 10, 2016 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 10, 2021 | $1.74M | Mar 22, 2022 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | 0 | Mar 22, 2022 |
| FY2021 | Dec 31, 2020 | 0 | Mar 22, 2022 |
| FY2020 | Dec 31, 2019 | 1 | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | 0 | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | 0 | Mar 14, 2019 |
| FY2017 | Dec 31, 2016 | 0 | Mar 14, 2018 |
| FY2016 | Dec 31, 2015 | 0 | Mar 24, 2017 |
| FY2015 | Dec 31, 2014 | (1) | Mar 10, 2016 |
| FY2015 | Dec 31, 2013 | (3) | Mar 10, 2016 |
| FY2014 | Dec 31, 2012 | 0 | Mar 20, 2015 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | 0 | Mar 22, 2022 |
| FY2021 | Dec 31, 2020 | 0 | Mar 22, 2022 |
| FY2020 | Dec 31, 2019 | 1 | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | 0 | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | 0 | Mar 14, 2019 |
| FY2017 | Dec 31, 2016 | 0 | Mar 14, 2018 |
| FY2016 | Dec 31, 2015 | 0 | Mar 24, 2017 |
| FY2015 | Dec 31, 2014 | (1) | Mar 10, 2016 |
| FY2015 | Dec 31, 2013 | (3) | Mar 10, 2016 |
| FY2014 | Dec 31, 2012 | 0 | Mar 20, 2015 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | 5.38M | Mar 22, 2022 |
| FY2021 | Dec 31, 2020 | 5.35M | Mar 22, 2022 |
| FY2020 | Dec 31, 2019 | 5.32M | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | 5.28M | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | 5.21M | Mar 14, 2019 |
| FY2017 | Dec 31, 2016 | 5.09M | Mar 14, 2018 |
| FY2016 | Dec 31, 2015 | 5.03M | Mar 24, 2017 |
| FY2015 | Dec 31, 2014 | 5.00M | Mar 10, 2016 |
| FY2014 | Dec 31, 2013 | 4.97M | Mar 20, 2015 |
| FY2013 | Dec 31, 2012 | 4.97M | Mar 6, 2014 |